Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEBENDAZOLE vs TRICLABENDAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEBENDAZOLE vs TRICLABENDAZOLE: Safety Overview

Metric MEBENDAZOLE TRICLABENDAZOLE
Total FAERS Reports 440 42
Deaths Reported 28 0
Death Rate 6.4% N/A
Hospitalizations 70 4
Average Patient Age 29.5 yrs 43.3 yrs
% Female Patients 68.4% 44.7%
FDA Approval Date Approved Prior to Jan 1, 1982 Feb 13, 2019
Manufacturer Janssen Pharmaceuticals, Inc. Novartis Pharmaceuticals Corporation
Route ORAL ORAL
Marketing Status Discontinued Prescription